Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:464-469
Published online before print January 5, 2004, doi: 10.1161/01.ATV.0000116028.42230.4c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/3/464    most recent
01.ATV.0000116028.42230.4cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirano, K.
Right arrow Articles by Kanaide, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirano, K.
Right arrow Articles by Kanaide, H.
Related Collections
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:464.)
© 2004 American Heart Association, Inc.


Vascular Biology

Transduction of the N-Terminal Fragments of MYPT1 Enhances Myofilament Ca2+ Sensitivity in an Intact Coronary Artery

Katsuya Hirano; Dmitry N. Derkach; Mayumi Hirano; Junji Nishimura; Shosuke Takahashi; Hideo Kanaide

From the Division of Molecular Cardiology, Research Institute of Angiocardiology (K.H., D.N.D., M.H., J.N., H.K.), the Department of Anesthesia and Critical Care Medicine (S.T.), and the Kyushu University COE Program on Lifestyle-Related Diseases (H.K.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Correspondence to Dr Hideo Kanaide, Professor, Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail kanaide{at}molcar.med.kyushu-u.ac.jp

Objective— The region of the 110 kDa regulatory subunit (MYPT1) of smooth muscle myosin phosphatase involved in the regulation of contraction was determined under physiological conditions.

Methods and Results— Using HIV Tat protein-mediated protein transduction, the N-terminal fragments of MYPT1 were introduced to the intact porcine coronary arterial strips. Pre-incubation with 3 µmol/L TAT-MYPT11–374, a construct containing the Tat peptide and the residues 1 to 374 of MYPT1, for 15 minutes augmented (2.4-fold) the subsequent contraction induced by adding 1.25 mmol/L of extracellular Ca2+ under 118 mmol/L K+ depolarization, with no augmentation of the [Ca2+]i elevation. The deletion of the Tat peptide, MYPT11–374, abolished the augmenting effect. TAT-MYPT11–296 demonstrated a weaker but significant augmentation (1.7-fold). However, TAT-MYPT11–171, TAT-MYPT139–374, TAT-MYPT139–296, and TAT-MYPT1297–374 had no augmenting activity. The myosin light chain phosphorylation level as a function of extracellular Ca2+ concentrations was shifted to the left in the strips pretreated with TAT-MYPT11–374 compared with the control.

Conclusions— Region 1 to 296 was the minimal region involved in the enhancement of contraction, and region 297 to 374 played a supplemental role. These results suggested that the interaction mainly between catalytic subunit and MYPT1 play a critical role in the regulation of the endogenous myosin phosphatase in intact smooth muscle.


Key Words: myosin • phosphatase • smooth muscle • contraction • protein transduction




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Hirano, N. Nomoto, M. Hirano, F. Momota, A. Hanada, and H. Kanaide
Distinct Ca2+ Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1 and PAR4) in Vascular Endothelial Cells
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 668 - 677.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Yufu, K. Hirano, D. Bi, M. Hirano, J. Nishimura, Y. Iwamoto, and H. Kanaide
Rac1 Regulation of Surface Expression of Protease-Activated Receptor-1 and Responsiveness to Thrombin in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1506 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Shiga, K. Hirano, M. Hirano, J. Nishimura, H. Nawata, and H. Kanaide
Long-Term Inhibition of RhoA Attenuates Vascular Contractility by Enhancing Endothelial NO Production in an Intact Rabbit Mesenteric Artery
Circ. Res., May 13, 2005; 96(9): 1014 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Bi, J. Nishimura, N. Niiro, K. Hirano, and H. Kanaide
Contractile Properties of the Cultured Vascular Smooth Muscle Cells: The Crucial Role Played by RhoA in the Regulation of Contractility
Circ. Res., April 29, 2005; 96(8): 890 - 897.
[Abstract] [Full Text] [PDF]